← Browse by Condition
Medical Condition

dm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07093476 Phase 3
Recruiting

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

Enrollment
171 pts
Location
South Korea
Sponsor
Celltrion
View Trial →